Retinopathy of prematurity blindness worldwide: phenotypes in the third epidemic
- PMID: 28539799
- PMCID: PMC5398741
- DOI: 10.2147/EB.S94436
Retinopathy of prematurity blindness worldwide: phenotypes in the third epidemic
Abstract
Blindness due to retinopathy of prematurity (ROP) is an increasing problem worldwide as improved levels of neonatal care are provided in countries with developing neonatal intensive care units. The occurrence of ROP blindness varies dramatically with the socioeconomic development of a country. In regions with high levels of neonatal care and adequate resources, ROP blindness is largely restricted to premature infants with very low birth weight and low gestational age while in middle- and low-income countries with regional variation in technology and capacity, limited health resources may well limit the care of the premature newborn.
Keywords: ROP; blindness; international.
Conflict of interest statement
Disclosure The author reports no conflicts of interest in this work.
Figures
References
-
- WHO . Global Initiative for the Elimination of Avoidable Blindness. WHO: Geneva; 1997. WHO/PBL/9761.
-
- Early Treatment for Retinopathy Of Prematurity Cooperative Group Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684–1694. - PubMed
-
- Rahi JS, Cable N. Severe visual impairment and blindness in children in the UK. Lancet. 2003;362:1359–1365. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
